Xiaogang Shu
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Infectious Diseases top 10%
- Neurology top 10%
- Topics
- Cancer Cells and Metastasis (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)Genetic factors in colorectal cancer (4 papers)
- Partner nations
- China
In The Last Decade
Xiaogang Shu
23 papers receiving 835 citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 422
- Oncology 246
- Cancer Research 226
- Infectious Diseases 161
- Neurology 112
Countries citing papers authored by Xiaogang Shu
This map shows the geographic impact of Xiaogang Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaogang Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaogang Shu more than expected).
Fields of papers citing papers by Xiaogang Shu
This network shows the impact of papers produced by Xiaogang Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaogang Shu. The network helps show where Xiaogang Shu may publish in the future.
Co-authorship network of co-authors of Xiaogang Shu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaogang Shu. A scholar is included among the top collaborators of Xiaogang Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaogang Shu. Xiaogang Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 40 | |
| 4 | 2 | |
| 5 | 214 | |
| 6 | 184 | |
| 7 | 20 | |
| 8 | 19 | |
| 9 | 31 | |
| 10 | 30 | |
| 11 | 35 | |
| 12 | 4 | |
| 13 | 32 | |
| 14 | 20 | |
| 15 | 10 | |
| 16 | 66 | |
| 17 | 51 | |
| 18 | 26 | |
| 19 | 12 | |
| 20 | [Effects of magnetic gemcitabine stealth nano-liposomes on the characteristics of breast cancer cell line MCF-7]. | 4 |
About Xiaogang Shu
Xiaogang Shu is a scholar working on Transplantation, Cancer Research and Oncology, having authored 23 papers that have together received 840 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Genetic factors in colorectal cancer (4 papers). The work is most often cited by research in Cancer Research (226 citations), Oncology (246 citations) and Infectious Diseases (161 citations). Xiaogang Shu has collaborated with scholars based in China. Frequent co-authors include Zili Zhou, Shengbo Han, Jinhuang Chen, Wenzheng Yuan, Zhengyi Liu, Yan Shu, Qiang Tang, Ning Zhao, Bin Chen and Jintong Ji. Their work appears in journals such as Gastroenterology, PLoS ONE and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.